News Industry News BIOMODEX Technology Enables New Milestone in Interventional Cardiology July 21, 2021
News Industry News New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events September 08, 2015